Paul E DiCorleto insider trades: Cleveland Biolabs (CBLI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2013 | CBLI | ↑ Buy | 6,210 | $1.61 | $10K | Direct | May 23, 2013 (2d) |
| Aug 15, 2011 | CBLI | ↑ Buy | 10,000 | $2.60 | $26K | Direct | Aug 15, 2011 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Paul E DiCorleto's insider trades
Paul E DiCorleto is a director at Cleveland Biolabs (CBLI). Since Aug 15, 2011, Paul has reported 2 open-market purchases worth $36K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.